Participants 195 351 5
medroxyprogesterone acetate (MPA) during postmenopausal hormone replacement therapy (HRT) in women with and without a history of premenstrual syndrome (PMS)
Participants 435 504 5
36 postmenopausal women at three health care areas in northern Sweden
